Oxcarbazepine and Amenorrhea
While oxcarbazepine is not directly documented to cause amenorrhea, women taking oxcarbazepine who experience amenorrhea require evaluation for multiple potential mechanisms including hormonal contraceptive failure, polycystic ovary changes, and underlying epilepsy-related reproductive dysfunction 1, 2.
Understanding the Connection
Oxcarbazepine affects reproductive function through several distinct pathways, though amenorrhea is not listed as a direct adverse effect in the FDA labeling 1:
Primary Mechanism: Contraceptive Failure
Oxcarbazepine significantly reduces the effectiveness of hormonal contraceptives containing ethinylestradiol and levonorgestrel, decreasing their plasma concentrations by approximately 47% 3. This occurs through:
- Induction of hepatic CYP3A-mediated metabolism
- Reduction in both estrogen and progestagen components
- Decreased half-lives of both hormones (ethinylestradiol from 13.6 to 7.9 hours) 3, 4
If you're on hormonal birth control and oxcarbazepine, contraceptive failure leading to pregnancy is the first consideration when periods stop 1.
Secondary Mechanism: Polycystic Ovary Changes
Research demonstrates that oxcarbazepine is associated with reproductive endocrine changes distinct from other antiepileptic drugs 2:
- High prevalence of polycystic ovaries (PCOs) in oxcarbazepine-treated women
- Elevated dehydroepiandrosterone sulfate (DHEAS) and androstenedione levels
- Paradoxically lower testosterone levels and free androgen index
- These changes can manifest as menstrual irregularities including amenorrhea 2
Tertiary Factor: Epilepsy-Related Dysfunction
Women with epilepsy have inherently higher rates of reproductive disorders 5:
- Hypothalamic amenorrhea occurs in 12% of women with temporal lobe epilepsy (vs. 1.5% in general population)
- Polycystic ovary syndrome affects 10-25% of women with temporal lobe epilepsy
- Functional hyperprolactinemia from seizure activity can cause amenorrhea 5
Required Evaluation Algorithm
When a woman on oxcarbazepine presents with amenorrhea, perform this systematic workup 5:
Immediate Assessment
- Pregnancy test - mandatory first step given contraceptive failure risk 1, 6
- Menstrual history - document cycle length, regularity, duration of amenorrhea (>6 months defines secondary amenorrhea) 5, 6
- Medication review - confirm oxcarbazepine dose, duration, and any hormonal contraceptive use 5
Hormonal Evaluation
Order these specific tests 5, 6:
- Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) - to differentiate hypothalamic, pituitary, or ovarian causes
- Prolactin - elevated in functional hyperprolactinemia from seizures 5
- Thyroid-stimulating hormone (TSH) - oxcarbazepine can affect thyroid function 1
- Testosterone and DHEAS - often elevated with oxcarbazepine-associated PCO 2
- Mid-luteal progesterone - to assess ovulation status 5
Imaging Studies
- Transvaginal pelvic ultrasound - more sensitive than transabdominal for detecting polycystic ovaries, indicated if hormonal tests suggest ovarian pathology 5
- Pituitary MRI - only if prolactin elevated or clinical features suggest pituitary pathology 5
Clinical Features to Document
- Weight changes - oxcarbazepine can cause weight gain, triggering PCOS in predisposed women 5
- Hirsutism, acne - signs of hyperandrogenism 5
- Galactorrhea - suggests hyperprolactinemia 5
- Seizure frequency and type - temporal lobe seizures particularly associated with reproductive dysfunction 5
Management Approach
If Using Hormonal Contraception
Switch to non-hormonal contraception immediately 1:
- Copper IUD
- Barrier methods
- Do NOT increase hormonal contraceptive dose - unreliable with oxcarbazepine
If Polycystic Ovary Changes Confirmed
Consider switching from oxcarbazepine to an alternative antiepileptic drug 2:
- Oxcarbazepine may be disadvantageous for women with hyperandrogenism
- Lamotrigine is a reasonable alternative without these effects
- Balance seizure control against reproductive dysfunction 5
If Hypothalamic Amenorrhea
Address underlying causes 5:
- Evaluate for stress, nutritional deficiency, excessive exercise
- Energy deficit correction if present
- Sequential estrogen-progestogen for bone health if hypoestrogenic
Critical Monitoring
Regular reproductive function monitoring is recommended for all women on oxcarbazepine 5:
- Question about menstrual patterns at each visit
- Monitor weight trends
- Assess for hirsutism, galactorrhea
- Particular attention to obese patients or those with significant weight gain
Important Caveats
Do not assume amenorrhea is benign - it may indicate:
- Unintended pregnancy from contraceptive failure
- Hypoestrogenism leading to bone loss
- Underlying endocrine pathology requiring treatment 5, 6
Single abnormal findings without symptoms may not require immediate intervention, but mandate close monitoring for development of symptomatic disorders 5.
The decision to change antiepileptic therapy must balance reproductive concerns against seizure control - switching medications carries seizure relapse risk 5.
Women with epilepsy-related reproductive dysfunction have increased infertility rates and may face higher risks of migraine, emotional disorders, and female malignancies 5. Anovulatory cycles may also increase seizure frequency 5.